Close

Biospecifics Technologies (BSTC) Tops Q3 EPS by 2c

November 10, 2014 8:30 AM EST

Biospecifics Technologies (NASDAQ: BSTC) reported Q3 EPS of $0.21, $0.02 better than the analyst estimate of $0.19. Revenue for the quarter came in at $4 million versus the consensus estimate of $4 million.

For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings